Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults

Author:

Wang Jiao1,Wang Zhimin1,Guo Feng1,Zhang Yinghui1,Ji Hongfei1,Chen Gang2,Wan Qin3,Yan Li4,Wang Guixia5,Qin Yingfen6,Luo Zuojie6,Tang Xulei7,Huo Yanan8,Hu Ruying9,Ye Zhen9,Shi Lixin10,Gao Zhengnan11,Su Qing12,Mu Yiming13,Zhao Jiajun14,Chen Lulu15,Zeng Tianshu15,Yu Xuefeng16,Li Qiang17,Shen Feixia18,Chen Li19,Zhang Yinfei20,Wang Youmin21,Deng Huacong22,Liu Chao23,Wu Shengli24,Yang Tao25ORCID,Li Mian26,Xu Yu26,Xu Min26ORCID,Zhao Zhiyun26,Wang Tiange26ORCID,Lu Jieli26,Bi Yufang26,Wang Weiqing26ORCID,Ning Guang26,Zhao Yanyan1ORCID,Qin Guijun1ORCID

Affiliation:

1. Division of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

2. Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China

3. The Affiliated Hospital of Luzhou Medical College, Luzhou, China

4. Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

5. The First Hospital of Jilin University, Changchun, China

6. The First Affiliated Hospital of Guangxi Medical University, Nanning, China

7. The First Hospital of Lanzhou University, Lanzhou, China

8. Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, China

9. Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China

10. Affiliated Hospital of Guiyang Medical College, Guiyang, China

11. Dalian Municipal Central Hospital, Dalian, China

12. Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China

13. Chinese People’s Liberation Army General Hospital, Beijing, China

14. Shandong Provincial Hospital affiliated to Shandong University, Jinan, China

15. Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

16. Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

17. The Second Affiliated Hospital of Harbin Medical University, Harbin, China

18. The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

19. Qilu Hospital of Shandong University, Jinan, China

20. Central Hospital of Shanghai Jiading District, Shanghai, China

21. The First Affiliated Hospital of Anhui Medical University, Hefei, China

22. The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

23. Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China

24. Karamay Municipal People’s Hospital, Xinjiang, China

25. The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

26. Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translationa

Abstract

Abstract Context Diabetes, hypertension and dyslipidemia accelerates the incidence of cardiovascular disease (CVD) events. However, data regarding the association between main cardiometabolic morbidities such as diabetes, hypertension, and dyslipidemia and the subsequent risk of CVD events in Chinese adults are still limited. Objective To investigate the associations between individual and combined cardiometabolic morbidities and incident cardiovascular events in Chinese adults. Methods Baseline data were obtained from a prospective, nationwide, and population-based cohort study in China during 2011–2012. A total of 133 572 participants aged ≥40 years were included in the study. The main outcome measures were CVD events. Results Compared with participants without diabetes, hypertension and dyslipidemia, participants with only diabetes (hazard ratio [HR], 1.58; 95% CI, 1.32-1.90) or only hypertension (2.04; 1.82-2.28) exhibited significantly higher risk for CVD events, while participants with only dyslipidemia (0.97; 0.84-1.12) exhibited no significantly higher risk for CVD events. When analyzed collectively, participants with diabetes plus hypertension (HR, 2.67; 95% CI, 2.33-3.06), diabetes plus dyslipidemia (1.57; 1.32-1.87), and hypertension plus dyslipidemia (2.12; 1.88-2.39) exhibited significantly higher risk for CVD. Moreover, participants with the combination of diabetes, hypertension, and dyslipidemia exhibited the highest risk for CVD events (HR, 3.06; 95% CI, 2.71-3.46). Multivariable-adjusted HRs (95% CIs) for CVD associated with diabetes based on fasting glucose ≥7.0 mmol/L, oral glucose tolerance test 2-hour glucose ≥11.1 mmol/L, and hemoglobin A1c ≥6.5% were 1.64 (1.51-1.78), 1.57 (1.45-1.69), and 1.54 (1.42-1.66), respectively; associated with hypertension based on systolic blood pressure ≥140 mmHg and diastolic blood pressure ≥90 mmHg were 1.89 (1.76-2.03) and 1.74 (1.60-1.88), respectively; associated with dyslipidemia based on total cholesterol ≥6.22 mmol/L, low-density lipoprotein cholesterol ≥4.14 mmol/L, high-density lipoprotein cholesterol <1.04 mmol/L, and triglycerides ≥2.26 mmol/L were 1.18 (1.08-1.30), 1.30 (1.17-1.44), 1.00 (0.92-1.09), and 1.10 (1.01-1.20), respectively. Conclusion Diabetes, hypertension and dyslipidemia showed additive associations with the risk of CVD events in middle-aged and elderly Chinese adults.

Funder

Shanghai Key Laboratory for Endocrine Tumors

National Key R&D Program of China

National Natural Science Foundation of China

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3